Mast Therapeutics (MSTX) Updates on Evaluation of Strategic Options; Received Interest from Private Companies
Tweet Send to a Friend
Mast Therapeutics, Inc. (NYSE: MSTX) provided an update regarding its recently announced campaign to evaluate strategic opportunities. Preliminary Indications of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE